Private equity firms sell $500M-plus in Quintiles shares; AMAG raises $201M;

@FierceBiotech: ICYMI Friday: Merck's Ebola vaccine is 100% successful in interim Phase III results. Report | Follow @FierceBiotech

@JohnCFierce: Is it just me, or is $SHPG's Ornskov overrated? Shire chief Ornskov bets $300M on another eye drug bolt-on buyout. Story | Follow @JohnCFierce

@DamianFierce: Charming addition to the drug co. nonsense lexicon: "biobetter." More | Follow @DamianFierce

> Private equity groups are selling more than $500 million worth of Quintiles ($Q) shares. Story

> AMAG Pharmaceuticals priced $201 million in shares. Release

> San Diego-based Cidara Therapeutics has launched a Phase I study of the antifungal CD101 IV in healthy subjects. Release

Medical Device News

@FierceMedDev: ICYMI Friday: Upstart gets $6M to back the first FDA-cleared, OTC conception assistance device. Article | Follow @FierceMedDev

@VarunSaxena2: ResMed acquires China's Curative Medical to get bigger in sleep disorder devices. Item | Follow @VarunSaxena2

@EmilyWFierce: $OSUR got an FDA OK for emergency use of its rapid Ebola test. Press release | Follow @EmilyWFierce

> U.S. Army scientists roll out innovative blood loss monitor device. More

> Bard gets additional CMS reimbursement for its drug-coated angioplasty balloon. Story

Pharma News

@FiercePharma: ICYMI: Suit says CVS manipulated generic drug prices. Item | Follow @FiercePharma

@EricPFierce: As #Hospira expands recall of #ketorolac to 37M vials you've got to wonder what Pfizer thinks. Article | Follow @EricPFierce

@CarlyHFierce: #ICYMI Friday: Ackman's 'wolf pack' drove Allergan into foreign hands, former CEO says. More | Follow @CarlyHFierce

> Express Scripts stiff-arms AZ's Onglyza, Vivus' Qsymia with new 2016 formulary. Article

> Ex-Teva employee said she got canned for passing info to the feds in Latin America fraud probe. News

Animal Health News

> VCA ups 2015 guidance as Q2 sales and profits soar past expectations. More

> Heska doubles Q2 operating income but misses on revenue. Report

> Schein misses Q2 estimates on currency woes and sales challenges. Story

> IDEXX shares climb on record diagnostics placements and Q2 earnings gain. Article

> Report: 'Precision farming' set to revolutionize livestock care. More

Biotech IT News

> Y Combinator continues push into bioinformatics with investment in Cofactor Genomics. News

> NIH to bankroll initiatives to build Cancer Genomics Cloud Pilots into R&D programs. Report

> Ex-BGI CEO's next move? A $1.6B push to find a 'formula for life.' More

> First startups graduate from Illumina Accelerator as deadline for next phase nears. Story

> Venter's HLI plans to ramp up sequencing capacity as more pharma deals near fruition. Article

Pharma Marketing News

> Express Scripts kicks another batch of meds off its preferred formulary. Item

> Pfizer's hot-selling Ibrance gets even hotter with new $710M sales estimate for 2015. News

> Sanofi and MannKind launch Afrezza DTC ad campaign in stealth mode. Story

> Shyft Analytics: Targeted drugs need a data-fueled marketing shift. Article

> Can a dwindling rep tally keep Vivus' obesity med in the game? More

Suggested Articles

Inovio CEO J. Joseph Kim is undeterred by short sellers and other detractors who doubt his company can shuttle a COVID-19 DNA vaccine to market.

Adding entinostat to hormone therapy did not help patients with HR-positive, HER2-negative breast cancer live longer.

The data add to the evidence in support of the IL-6 drug ahead of a FDA decision to approve it in a rare disease served by Alexion’s Soliris.